NCT05078671View on ClinicalTrials.gov

Pharmacokinetic Boosting of Olaparib to Improve Exposure, Tolerance and Cost-effectiveness

PHASE4RecruitingINTERVENTIONAL
Enrollment

160

Participants

Timeline

Start Date

December 15, 2021

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Cancer
Interventions
DRUG

Olaparib

olaparib treatment

DRUG

Cobicistat

Pharmacokinetic booster

Trial Locations (10)

Unknown

RECRUITING

Jeroen Bosch Ziekenhuis, 's-Hertogenbosch

RECRUITING

Amsterdam Universitair Medische Centra, Amsterdam

RECRUITING

Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam

RECRUITING

Amphia Ziekenhuis, Breda

RECRUITING

Universitair Medisch Centrum Groningen, Groningen

RECRUITING

Leiden University Medical Center, Leiden

RECRUITING

Maastricht UMC, Maastricht

RECRUITING

Radboudumc, Nijmegen

RECRUITING

ErasmusMC, Rotterdam

RECRUITING

Universitair Medisch Centrum Utrecht, Utrecht

All Listed Sponsors
lead

Radboud University Medical Center

OTHER